Home > News > featured news > Concord Health Partners Adds Healthcare Veteran Brian Gragnolati as Executive Partner

Future of Healthcare

Concord Health Partners Adds Healthcare Veteran Brian Gragnolati as Executive Partner

Concord Health Partners | July 12, 2022 | Read time : 2 min

Concord Health

Concord Health Partners a healthcare focused investment firm, announced that Brian Gragnolati has joined as Executive Partner. Gragnolati currently serves as President and CEO of Atlantic Health System. During his tenure at Atlantic Health System, he also served as Chairman of the Board of Trustees of the American Hospital Association.     

The addition of Gragnolati as Executive Partner further expands Concord's team of healthcare sector specialists, adding the network, knowledge and insights of an experienced CEO and a nationally recognized leader in the provider industry. Gragnolati will work with James Olsen, Founder and Managing Partner, and other members of the Concord team to source new investment opportunities, support management teams and accelerate the growth of portfolio companies through commercial introductions across the Concord network of strategic relationships. 

"We are thrilled to add someone with Brian's experience, knowledge and expertise to Concord's executive team. We established Concord with the goal of creating lasting partnerships with strategic investors to help drive the adoption of our portfolio company technologies and solutions across a broad universe of healthcare providers and payors. Brian brings unique perspective from his roles as a health system chief executive officer and at the AHA, and has distinguished himself as a valuable partner to Concord in those roles. We look forward to leveraging his insights and network as he helps identify new opportunities and accelerate growth at our portfolio companies as Executive Partner." 

James Olsen, Founder and Managing Partner at Concord

"In working with Concord over the years, it was clear that the Firm has developed a powerful model for healthcare investing. Concord has become a leader in identifying innovative companies and partnering with them to drive growth," said Gragnolati. "I am excited at the opportunity to work even more closely with the Concord team and their portfolio companies to help them continue to deliver solutions that lower costs, improve quality and expand access to care." 

Gragnolati has served as President and CEO of Atlantic Heath System since 2015, and is the former Chairman of the Board of Trustees of the AHA.  Prior to his tenure at Atlantic Health, Brian served as Senior Vice President at Johns Hopkins Medicine. He previously held executive positions at Wellspan Health, University of Vermont Medical Center and Baystate Medical Center in Springfield, MA. As a nationally respected voice in health care, Mr. Gragnolati played a key role in public relations and media communications during the COVID pandemic. He regularly appears on CNBC, MSNBC, Bloomberg and other media outlets to share his insight on the nation's most pressing health concerns. He has been honored by Modern Healthcare as one of the 100 most influential people in healthcare. He serves on the Board of Directors of Lakeland Bancorp, Inc. and Lakeland Bank. Gragnolati holds a bachelor's degree in Health Systems Analysis from the University of Connecticut, an MBA from Western New England College and an Executive Leadership Certificate from the JFK School at Harvard University. 

About Concord Health Partners
Concord Health Partners is a healthcare focused investment firm with a strategic model that optimizes the alignment of interests between investors and portfolio companies. Concord has developed a broad network of  strategic investors that contribute expertise and resources, and serve as potential commercial partners to portfolio companies. Concord is primarily focused on investing in healthcare companies that have the potential to enhance the value of care through products, services, technologies and solutions that lower costs, improve quality and expand access to care. 

Spotlight

GE HealthCare LifeCycle Solutions Circular Economy

The video highlights the programs and processes GE HealthCare uses in creating a circular economy for our medical imaging equipment.  We work globally to reuse, recycle, repair and refurbish our GE HealthCare systems and parts, helping to create a more sustainable future.

More featured news

Spotlight

GE HealthCare LifeCycle Solutions Circular Economy

The video highlights the programs and processes GE HealthCare uses in creating a circular economy for our medical imaging equipment.  We work globally to reuse, recycle, repair and refurbish our GE HealthCare systems and parts, helping to create a more sustainable future.

Related News

Health Technology, Digital Healthcare

Best Buy Health and Geisinger Enhance Home Chronic Disease Management

Geisinger | September 13, 2023

Collaborating with Best Buy's Geek Squad ensures faster care, better adherence, and superior outcomes for chronic care patients. In 2021, Geisinger launched ConnectedCare365, enrolling over 1,100 patients in remote monitoring for various chronic conditions via Best Buy Health's Current Health platform. In July 2022, Best Buy Health and Geisinger began a program with Geek Squad Agents to deliver and activate remote care management devices. Best Buy Health and Geisinger have announced their commitment to expand their collaborative efforts to enhance the quality of care for a broader patient population within the Geisinger network. This expansion builds upon their successful delivery of in-home care to patients with chronic conditions through Geek Squad. This initiative currently encompasses 300 Geisinger patients. During their home visits, these agents critically educate patients about the technology integral to their care plan. They offer detailed explanations about the devices, instruct patients on proper usage, and ensure seamless data transmission to the patient's care team. Additionally, agents are available to help with troubleshooting as needed, and they oversee the collection and processing of all devices after a patient leaves the program, following the care team's instructions. The program has achieved a remarkable 50% reduction in the time it takes for a patient to go from admission into the chronic care at-home program to the completion of device setup. This pivotal shift has seen the period shrink from an average of 96 hours to just 48 hours. Furthermore, patients' adherence to their care plans has improved by a commendable 19%, evident in their consistent use of remote technology equipment. Additionally, there has been an 18% decline in reported technical issues, and when replacements were necessary, Geek Squad agents swiftly provided new devices within 24 hours of receiving reports. These exceptional results have garnered positive patient feedback, with a net promoter score of 89 when asked about their experience with Geek Squad's home visits for chronic care program setup. Deborah Di Sanzo, President of Best Buy Health, stated, The results of our program show that when we combine what Best Buy is known for—technology support and expertise—with Geisinger's best-in-class care teams and network of clinics and hospitals, we can make a meaningful difference in the patient and caregiver experience. [Source: Business Wire] Additionally, she emphasized Geisinger's outstanding performance on this initiative. She expressed strong enthusiasm for expanding these capabilities nationwide, in alignment with Best Buy Health's mission to promote accessible at-home care for everyone. Karen Murphy, EVP, Chief Innovation Officer and Founding Director of the Steele Institute for Health Innovation at Geisinger, emphasized the dynamic changes in healthcare. She highlighted the organization's heightened dedication to bringing care closer to patients and members while striving to establish higher care quality standards. The collaboration with Best Buy Health has enabled Geisinger to reshape the healthcare experience, ushering in positive transformations in care delivery and reception. Best Buy aims to enhance lives through technology by providing customers with expert guidance, a diverse product range, and comprehensive in-store and online services. Meanwhile, Geisinger dedicates itself to simplifying the journey to improved health for its extensive community of over one million individuals.

Read More

Health Technology, Digital Healthcare

DrFirst Healthcare Innovations Collaborates with MEDITECH to Power E-Prescribing in Canada

PRNewswire | August 10, 2023

DrFirst Healthcare Innovations announced today it is collaborating with MEDITECH to enable electronic prescribing by hospitals using the Expanse EHR in Canada. This integration supports MEDITECH's plans with Canada Health Infoway to connect with its national e-prescribing service, PrescribeIT®. E-prescribing has numerous benefits for physicians, pharmacies, and patients, including eliminating the need for faxing or calling-in prescriptions to pharmacies, avoiding transcription errors, reducing the potential for fraud, and saving time for patients who no longer need to drop off a written prescription at the pharmacy. DrFirst Healthcare Innovations is integrated with the MEDITECH Expanse EHR to provide the directory of community pharmacies and to meet the complex technical requirements for secure electronic prescribing through PrescribeIT®. "E-prescribing is safer for patients and more efficient for prescribers and pharmacists," said G. Cameron Deemer, CEO of DrFirst Healthcare Innovations. "We have a long history of working with MEDITECH, and we are thrilled to collaborate on this initiative to introduce e-prescribing and accelerate its adoption in Canada to benefit patients, hospitals, and pharmacies." In May, MEDITECH announced that Humber River Health in Toronto, ON, will be MEDITECH's first hospital in Canada to implement PrescribeIT® within the Expanse EHR and is expected to go live with the technology this fall. "The introduction of e-prescribing in Canada is transformative. This integration with DrFirst Healthcare Innovations will further our collaboration with Canada Health Infoway and PrescribeIT® and ultimately provides safer and more efficient healthcare delivery, as well as greater convenience for patients," said Robert Molloy, MEDITECH Director, Canadian Market and Product Strategy. "The partnership between MEDITECH and DrFirst marks a significant step forward in PrescribeIT's mission to transform how prescriptions are sent and received," said Jamie Bruce, EVP, PrescribeIT®. "This collaboration will enhance patient care, streamline workflows, and empower healthcare professionals with a seamless and secure prescribing experience." DrFirst Healthcare Innovations is a long-time partner of MEDITECH in hospitals throughout the U.S. for e-prescribing and other medication management solutions, including augmented intelligence to increase productivity and streamline the collection of patients' medication history to better inform prescribing decisions. About DrFirst Healthcare Innovations Since 2000, healthcare IT pioneer DrFirst has empowered providers and patients to achieve better health through intelligent medication management and has been active in Canada since 2015 via its wholly-owned subsidiary, DrFirst Healthcare Innovations. We improve healthcare efficiency and effectiveness by enhancing e-prescribing workflows, improving medication history, optimizing clinical data usability, and helping patients start and stay on therapy. In the last few years, DrFirst has won over 25 awards for excellence and innovation, including winning Gold in the prestigious Edison Awards in 2023, recognizing our game-changing use of clinical-grade AI to streamline time-consuming healthcare workflows and prevent medication errors.

Read More

Health Technology, Healthcare Analytics

Capital Rx Launches Rx Reverse in Partnership with Virta Health to Combat Type 2 Diabetes and Obesity

PRNewswire | July 18, 2023

Capital Rx, the health technology company changing the way prescription drugs are priced and patients are cared for, and type 2 diabetes (T2D) reversal leader Virta Health have partnered to introduce Rx Reverse. Available to all of Capital Rx's customers, Rx Reverse is a high-touch, provider-led, integrated clinical program designed to help members reverse T2D and fight obesity without costly medications. The problem is clear: 37+ million Americans have been diagnosed with diabetes, and over 90% of them have T2D (including one-third of the population over 65 years old).1 At the same time, the prevalence of obesity is over 40% of the U.S. population2 and is expected to reach nearly 50% by 2030.3 During a June 15, 2023 webinar, Rethinking Obesity Strategies: The Rise of GLP-1 Drugs and Lifestyle Programs for Weight Loss, Virta revealed new survey data highlighting that diabetes and obesity are the #1 and #2 concerns of health plan leaders in 2023 because of rising costs and downstream health impact. The launch of Rx Reverse comes as demand for GLP-1 drugs approved for diabetes and weight loss is rising rapidly, and employers and health plan leaders focus on managing the cost of diabetes and obesity. Rx Reverse combines Capital Rx's tech-enabled pharmacy benefit management (PBM) service model, powered by JUDI®, and Virta's solution – personalized nutrition therapy, physician-led deprescription, remote monitoring, and one-on-one coaching – to help health plans reduce costs and improve members' health. "Leveraging JUDI, our proprietary next-generation claim adjudication platform for Medicare, Medicaid, and commercial plans, we have the ability to seamlessly connect with vendors like Virta, sharing actionable member information efficiently in real-time, and providing the connectivity plan members need to improve their overall health," said Sara Izadi, PharmD, Senior Vice President of Pharmacy at Capital Rx. "Our Single-Ledger Model™, coupled with JUDI's capabilities, enables us to partner with Virta on a solution focused on deprescribing and health equity." Virta reports lowering HbA1c for patients by 1.3% on average after one year, and 60% of patients enrolled one year attained an HbA1c below 6.5% without using diabetes medications other than metformin. Moreover, patients experience an average of 12% body weight loss at two years. And like Capital Rx, which saves payers 10% - 30% in the first year, on average, after switching from a traditional PBM model, Virta emphasizes positive financial outcomes, including demonstrating an estimated $503 per engaged member per month gross savings for T2D reversal participants. Three Rx Reverse options are available for plan sponsors to choose from Type 2 Diabetes Reversal: Helps plan members achieve lower blood sugar – often to sub-diabetes levels <6.5 A1c – and clinically significant weight loss alongside safe deprescription of diabetes medication. Provider-Led Weight Loss: Helps plan members without diabetes who are considered overweight (BMI ≥ 25) or obese (BMI ≥ 30) achieve clinically significant weight loss. Type 2 Diabetes Reversal & Provider-Led Weight Loss "The rapidly rising utilization and cost of obesity and diabetes drugs is putting extreme pressure on healthcare payers," said Kevin Kumler, President at Virta Health. "Capital Rx's tech-forward, value-based approach – a needed evolution from the traditional PBM model – aligns both incentives and systems to help payers control drug costs while members get healthier." About Virta Health Virta Health is the leader in type 2 diabetes reversal and is creating a new standard in medical care for people living with type 2 diabetes, prediabetes, or obesity. The company's virtual approach combines personalized nutrition therapy with continuous provider-led support to empower members to eliminate medications, lose weight, and take back their lives. Virta has earned the trust of the nation's largest organizations, including Humana, AutoZone, and Blue Shield of California, delivering industry-leading cost savings of over $6,000 per member per year while putting our fees at risk based on health outcomes. About Capital Rx Capital Rx is a healthcare technology company changing the way prescription drugs are priced and patients are cared for in America. As a Certified B Corp™, Capital Rx is executing its mission through a Single-Ledger Model™, the industry's first ethical framework for drug pricing. The company's cloud-native enterprise pharmacy platform, JUDI®, connects every aspect of the pharmacy ecosystem, servicing over 2.4 million members for Medicare, Medicaid, and commercial plans.

Read More

Health Technology, Digital Healthcare

Best Buy Health and Geisinger Enhance Home Chronic Disease Management

Geisinger | September 13, 2023

Collaborating with Best Buy's Geek Squad ensures faster care, better adherence, and superior outcomes for chronic care patients. In 2021, Geisinger launched ConnectedCare365, enrolling over 1,100 patients in remote monitoring for various chronic conditions via Best Buy Health's Current Health platform. In July 2022, Best Buy Health and Geisinger began a program with Geek Squad Agents to deliver and activate remote care management devices. Best Buy Health and Geisinger have announced their commitment to expand their collaborative efforts to enhance the quality of care for a broader patient population within the Geisinger network. This expansion builds upon their successful delivery of in-home care to patients with chronic conditions through Geek Squad. This initiative currently encompasses 300 Geisinger patients. During their home visits, these agents critically educate patients about the technology integral to their care plan. They offer detailed explanations about the devices, instruct patients on proper usage, and ensure seamless data transmission to the patient's care team. Additionally, agents are available to help with troubleshooting as needed, and they oversee the collection and processing of all devices after a patient leaves the program, following the care team's instructions. The program has achieved a remarkable 50% reduction in the time it takes for a patient to go from admission into the chronic care at-home program to the completion of device setup. This pivotal shift has seen the period shrink from an average of 96 hours to just 48 hours. Furthermore, patients' adherence to their care plans has improved by a commendable 19%, evident in their consistent use of remote technology equipment. Additionally, there has been an 18% decline in reported technical issues, and when replacements were necessary, Geek Squad agents swiftly provided new devices within 24 hours of receiving reports. These exceptional results have garnered positive patient feedback, with a net promoter score of 89 when asked about their experience with Geek Squad's home visits for chronic care program setup. Deborah Di Sanzo, President of Best Buy Health, stated, The results of our program show that when we combine what Best Buy is known for—technology support and expertise—with Geisinger's best-in-class care teams and network of clinics and hospitals, we can make a meaningful difference in the patient and caregiver experience. [Source: Business Wire] Additionally, she emphasized Geisinger's outstanding performance on this initiative. She expressed strong enthusiasm for expanding these capabilities nationwide, in alignment with Best Buy Health's mission to promote accessible at-home care for everyone. Karen Murphy, EVP, Chief Innovation Officer and Founding Director of the Steele Institute for Health Innovation at Geisinger, emphasized the dynamic changes in healthcare. She highlighted the organization's heightened dedication to bringing care closer to patients and members while striving to establish higher care quality standards. The collaboration with Best Buy Health has enabled Geisinger to reshape the healthcare experience, ushering in positive transformations in care delivery and reception. Best Buy aims to enhance lives through technology by providing customers with expert guidance, a diverse product range, and comprehensive in-store and online services. Meanwhile, Geisinger dedicates itself to simplifying the journey to improved health for its extensive community of over one million individuals.

Read More

Health Technology, Digital Healthcare

DrFirst Healthcare Innovations Collaborates with MEDITECH to Power E-Prescribing in Canada

PRNewswire | August 10, 2023

DrFirst Healthcare Innovations announced today it is collaborating with MEDITECH to enable electronic prescribing by hospitals using the Expanse EHR in Canada. This integration supports MEDITECH's plans with Canada Health Infoway to connect with its national e-prescribing service, PrescribeIT®. E-prescribing has numerous benefits for physicians, pharmacies, and patients, including eliminating the need for faxing or calling-in prescriptions to pharmacies, avoiding transcription errors, reducing the potential for fraud, and saving time for patients who no longer need to drop off a written prescription at the pharmacy. DrFirst Healthcare Innovations is integrated with the MEDITECH Expanse EHR to provide the directory of community pharmacies and to meet the complex technical requirements for secure electronic prescribing through PrescribeIT®. "E-prescribing is safer for patients and more efficient for prescribers and pharmacists," said G. Cameron Deemer, CEO of DrFirst Healthcare Innovations. "We have a long history of working with MEDITECH, and we are thrilled to collaborate on this initiative to introduce e-prescribing and accelerate its adoption in Canada to benefit patients, hospitals, and pharmacies." In May, MEDITECH announced that Humber River Health in Toronto, ON, will be MEDITECH's first hospital in Canada to implement PrescribeIT® within the Expanse EHR and is expected to go live with the technology this fall. "The introduction of e-prescribing in Canada is transformative. This integration with DrFirst Healthcare Innovations will further our collaboration with Canada Health Infoway and PrescribeIT® and ultimately provides safer and more efficient healthcare delivery, as well as greater convenience for patients," said Robert Molloy, MEDITECH Director, Canadian Market and Product Strategy. "The partnership between MEDITECH and DrFirst marks a significant step forward in PrescribeIT's mission to transform how prescriptions are sent and received," said Jamie Bruce, EVP, PrescribeIT®. "This collaboration will enhance patient care, streamline workflows, and empower healthcare professionals with a seamless and secure prescribing experience." DrFirst Healthcare Innovations is a long-time partner of MEDITECH in hospitals throughout the U.S. for e-prescribing and other medication management solutions, including augmented intelligence to increase productivity and streamline the collection of patients' medication history to better inform prescribing decisions. About DrFirst Healthcare Innovations Since 2000, healthcare IT pioneer DrFirst has empowered providers and patients to achieve better health through intelligent medication management and has been active in Canada since 2015 via its wholly-owned subsidiary, DrFirst Healthcare Innovations. We improve healthcare efficiency and effectiveness by enhancing e-prescribing workflows, improving medication history, optimizing clinical data usability, and helping patients start and stay on therapy. In the last few years, DrFirst has won over 25 awards for excellence and innovation, including winning Gold in the prestigious Edison Awards in 2023, recognizing our game-changing use of clinical-grade AI to streamline time-consuming healthcare workflows and prevent medication errors.

Read More

Health Technology, Healthcare Analytics

Capital Rx Launches Rx Reverse in Partnership with Virta Health to Combat Type 2 Diabetes and Obesity

PRNewswire | July 18, 2023

Capital Rx, the health technology company changing the way prescription drugs are priced and patients are cared for, and type 2 diabetes (T2D) reversal leader Virta Health have partnered to introduce Rx Reverse. Available to all of Capital Rx's customers, Rx Reverse is a high-touch, provider-led, integrated clinical program designed to help members reverse T2D and fight obesity without costly medications. The problem is clear: 37+ million Americans have been diagnosed with diabetes, and over 90% of them have T2D (including one-third of the population over 65 years old).1 At the same time, the prevalence of obesity is over 40% of the U.S. population2 and is expected to reach nearly 50% by 2030.3 During a June 15, 2023 webinar, Rethinking Obesity Strategies: The Rise of GLP-1 Drugs and Lifestyle Programs for Weight Loss, Virta revealed new survey data highlighting that diabetes and obesity are the #1 and #2 concerns of health plan leaders in 2023 because of rising costs and downstream health impact. The launch of Rx Reverse comes as demand for GLP-1 drugs approved for diabetes and weight loss is rising rapidly, and employers and health plan leaders focus on managing the cost of diabetes and obesity. Rx Reverse combines Capital Rx's tech-enabled pharmacy benefit management (PBM) service model, powered by JUDI®, and Virta's solution – personalized nutrition therapy, physician-led deprescription, remote monitoring, and one-on-one coaching – to help health plans reduce costs and improve members' health. "Leveraging JUDI, our proprietary next-generation claim adjudication platform for Medicare, Medicaid, and commercial plans, we have the ability to seamlessly connect with vendors like Virta, sharing actionable member information efficiently in real-time, and providing the connectivity plan members need to improve their overall health," said Sara Izadi, PharmD, Senior Vice President of Pharmacy at Capital Rx. "Our Single-Ledger Model™, coupled with JUDI's capabilities, enables us to partner with Virta on a solution focused on deprescribing and health equity." Virta reports lowering HbA1c for patients by 1.3% on average after one year, and 60% of patients enrolled one year attained an HbA1c below 6.5% without using diabetes medications other than metformin. Moreover, patients experience an average of 12% body weight loss at two years. And like Capital Rx, which saves payers 10% - 30% in the first year, on average, after switching from a traditional PBM model, Virta emphasizes positive financial outcomes, including demonstrating an estimated $503 per engaged member per month gross savings for T2D reversal participants. Three Rx Reverse options are available for plan sponsors to choose from Type 2 Diabetes Reversal: Helps plan members achieve lower blood sugar – often to sub-diabetes levels <6.5 A1c – and clinically significant weight loss alongside safe deprescription of diabetes medication. Provider-Led Weight Loss: Helps plan members without diabetes who are considered overweight (BMI ≥ 25) or obese (BMI ≥ 30) achieve clinically significant weight loss. Type 2 Diabetes Reversal & Provider-Led Weight Loss "The rapidly rising utilization and cost of obesity and diabetes drugs is putting extreme pressure on healthcare payers," said Kevin Kumler, President at Virta Health. "Capital Rx's tech-forward, value-based approach – a needed evolution from the traditional PBM model – aligns both incentives and systems to help payers control drug costs while members get healthier." About Virta Health Virta Health is the leader in type 2 diabetes reversal and is creating a new standard in medical care for people living with type 2 diabetes, prediabetes, or obesity. The company's virtual approach combines personalized nutrition therapy with continuous provider-led support to empower members to eliminate medications, lose weight, and take back their lives. Virta has earned the trust of the nation's largest organizations, including Humana, AutoZone, and Blue Shield of California, delivering industry-leading cost savings of over $6,000 per member per year while putting our fees at risk based on health outcomes. About Capital Rx Capital Rx is a healthcare technology company changing the way prescription drugs are priced and patients are cared for in America. As a Certified B Corp™, Capital Rx is executing its mission through a Single-Ledger Model™, the industry's first ethical framework for drug pricing. The company's cloud-native enterprise pharmacy platform, JUDI®, connects every aspect of the pharmacy ecosystem, servicing over 2.4 million members for Medicare, Medicaid, and commercial plans.

Read More

More featured news